433 related articles for article (PubMed ID: 15931648)
1. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients.
Szeto CC; Lai KB; Chow KM; Szeto CY; Li PK
J Nephrol; 2005; 18(2):197-203. PubMed ID: 15931648
[TBL] [Abstract][Full Text] [Related]
2. The relationship between bone morphogenic protein-7 and peritoneal transport characteristics.
Szeto CC; Chow KM; Kwan BC; Lai KB; Chung KY; Leung CB; Li PK
Nephrol Dial Transplant; 2008 Sep; 23(9):2989-94. PubMed ID: 18400816
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
4. Water channel AQP1, 3, and 4 in the human peritoneum and peritoneal dialysate.
Akiba T; Ota T; Fushimi K; Tamura H; Hata T; Sasaki S; Marumo F
Adv Perit Dial; 1997; 13():3-6. PubMed ID: 9360641
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
del Peso G; Fernández-Reyes MJ; Hevia C; Bajo MA; Castro MJ; Cirugeda A; Sánchez-Tomero JA; Selgas R
Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
[TBL] [Abstract][Full Text] [Related]
7. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
8. Expression of aquaporin-1 in the human peritoneum and the effect of peritoneal dialysis on its expression.
Fang W; Qian J; Yu Z; Chen S
Chin Med J (Engl); 2003 Sep; 116(9):1370-3. PubMed ID: 14527368
[TBL] [Abstract][Full Text] [Related]
9. The cellular contribution to effluent potassium and its relation to free water transport during peritoneal dialysis.
Coester AM; Struijk DG; Smit W; de Waart DR; Krediet RT
Nephrol Dial Transplant; 2007 Dec; 22(12):3593-600. PubMed ID: 17664179
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
Clerbaux G; Francart J; Wallemacq P; Robert A; Goffin E
Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 4G/5G genetic polymorphism does not affect peritoneal transport characteristic.
Szeto CC; Poon P; Szeto CY; Wong TY; Lai KB; Li PK
Am J Kidney Dis; 2002 May; 39(5):1061-7. PubMed ID: 11979351
[TBL] [Abstract][Full Text] [Related]
12. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
Zweers MM; Struijk DG; Smit W; Krediet RT
J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
[TBL] [Abstract][Full Text] [Related]
14. Dialysate CA125 in stable CAPD patients: no relation with transport parameters.
Pannekeet MM; Koomen GC; Struijk DG; Krediet RT
Clin Nephrol; 1995 Oct; 44(4):248-54. PubMed ID: 8575125
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF) levels in peritoneal dialysis effluent.
Selgas R; del Peso G; Bajo MA; Molina S; Cirugeda A; Sánchez-Tomero JA; Castro MJ; Castro MA; Vara F
J Nephrol; 2001; 14(4):270-4. PubMed ID: 11506249
[TBL] [Abstract][Full Text] [Related]
19. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the dialysis adequacy and transport test in peritoneal dialysis.
Seo JJ; Kim YL; Park SH; Kim CD; Kim JC; Jang MH; Choi HJ
Adv Perit Dial; 2005; 21():25-30. PubMed ID: 16686280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
